The Affiliated Hospital of Xuzhou Medical University
Welcome,         Profile    Billing    Logout  
 323 Trials 
1363 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Li, Li
NCT04146155: Efficacy and Safety of Liraglutide in Type 2 Diabetes With Lower Extremity Arterial Disease

Recruiting
4
200
RoW
Liraglutide+standard-of-care treatment, Victoza, standard-of-care treatment
Second Affiliated Hospital, School of Medicine, Zhejiang University
Type 2 Diabetes, Peripheral Vascular Disorder Due to Diabetes Mellitus
12/21
12/21
NCT04713358: Effect of Nalmefene on the Quality of Resuscitation in Patients Under General Anesthesia

Recruiting
4
520
RoW
Nalmefene, normal Saline
RenJi Hospital, Shanghai Tong Ren Hospital, First Affiliated Hospital of Guangxi Medical University, The First Affiliated Hospital of Zhengzhou University
Resuscitation
12/23
12/23
ERASE, NCT06093191: Tobramycin Inhalation Solution for Pseudomonas Aeruginosa Eradication in Bronchiectasis

Recruiting
4
364
RoW
Tobramycin Inhalant Product, Inhaled antibiotics, Ciprofloxacin 750 MG, Oral antibiotics, Oral ciprofloxacin placebo, Natural saline inhalation, Inhaled saline
Shanghai Pulmonary Hospital, Shanghai, China
Bronchiectasis Adult, Pseudomonas Aeruginosa Infection
10/25
12/25
NCT05622890: A Single-arm Clinical Trial of IMGN853 in Chinese Adult Patients With Platinum-resistant, Epithelial Ovarian Cancer

Recruiting
3
35
RoW
Mirvetuximab Soravtansine, IMGN853, MIRV
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
Epithelial Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer
04/23
12/23
NCT06697522: Study of Atropine Sulfate Eye Drops(0.01%) in Treating Near-work-induced Transient Myopia in Children

Completed
3
148
RoW
Atropine Sulfate, Investigational product, Placebo, Blank Solvent
Ocumension Therapeutics (Suzhou) Co., Ltd, Beijing Children's Hospital
Myopia
10/23
03/24
NCT05793892: Efficacy and Safety of Lidocaine and Tetracaine Cream for Facial Laser Aesthetics in Chinese Adults

Completed
3
286
RoW
Lidocaine tetracaine cream, test drug:CU-30101, control drug:Pliaglis
Cutia Therapeutics(Wuxi)Co.,Ltd
Analgesia
08/23
10/23
QWINT-2, NCT05362058: A Study of Insulin Efsitora Alfa (LY3209590) Compared to Degludec in Adults With Type 2 Diabetes Who Are Starting Basal Insulin for the First Time

Completed
3
928
Europe, Canada, Japan, US, RoW
Insulin Efsitora Alfa, LY3209590 and Basal Insulin-FC, Insulin Degludec
Eli Lilly and Company
Diabetes, Type 2 Diabetes
04/24
04/24
ATTAIN-OSA, NCT06649045: A Master Protocol for Orforglipron in Participants With Obstructive Sleep Apnea and Obesity or Overweight

Recruiting
3
600
Europe, Japan, US, RoW
Orforglipron, LY3502970, Placebo
Eli Lilly and Company
OSA, Overweight or Obesity
11/26
01/27
NCT06717152: Efficacy and Safety of SJP-0132 Eye Drops in Chinese Patients With Dry Eye Disease

Recruiting
3
400
RoW
SJP-0132, Placebo
Senju Pharmaceutical Science & Technology (Beijing) Co., Ltd., Senju Pharmaceutical Co., Ltd.
Dry Eye
07/25
08/25
ATTAIN-1, NCT05869903: A Study of Orforglipron (LY3502970) in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities

Active, not recruiting
3
3000
Europe, Japan, US, RoW
Orforglipron, LY3502970, Placebo
Eli Lilly and Company
Obesity, Overweight, Overweight or Obesity
07/25
07/27
TRIUMPH-1, NCT05929066: A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight

Active, not recruiting
3
2300
Europe, Canada, US, RoW
Retatrutide, LY3437943, Placebo
Eli Lilly and Company
Obesity, Overweight, Osteoarthritis, Knee, Obstructive Sleep Apnea
04/26
05/26
Keypoint-1, NCT05302011: Neoadjuvant Pembrolizumab Plus Chemotherapy for Resectable Locally Advanced Esophageal Squamous Cell Carcinoma

Completed
2
28
RoW
Pembrolizumab, Carboplatin or Cisplatin, chemotherapy, Docetaxel
Peking Union Medical College Hospital
Esophageal Squamous Cell Carcinoma
03/23
06/23
NCT06161272: Fluzoparib With or Without Apatinib in Platinum-sensitive Relapsed Ovarian Cancer Previously Treated With PARPi

Not yet recruiting
2
80
RoW
Fluzoparib, Fluzoparib+Apatinib
Guangxi Medical University
Ovarian Cancer, High Grade Serous Adenocarcinoma of Ovary, Primary Peritoneal Carcinoma, Fallopian Tube Cancer
03/25
01/26
NCT06176235: Teriflunomide Plus High-dose Dexamethasone as First-line Treatment in Newly Diagnosed Primary Immune Thrombocytopenia

Recruiting
2
132
RoW
Teriflunomide, AUBAGIO, Dexamethasone
Peking University People's Hospital, Beijing Luhe Hospital, Chinese PLA General Hospital, Navy General Hospital, Beijing, Beijing Hospital, Beijing Friendship Hospital, Peking University First Hospital, Peking University Third Hospital, China-Japan Friendship Hospital, Beijing Tsinghua Changgeng Hospital
Immune Thrombocytopenia
12/24
05/25
NCT05932524: Low-dose Baricitinib Plus High-dose Dexamethasone for Patients With Newly Diagnosed Immune Thrombocytopenia

Recruiting
2
132
RoW
Baricitinib 2 MG, Olumiant, Dexamethasone, HD-DXM
Peking University People's Hospital, Beijing Luhe Hospital, Chinese PLA General Hospital, Navy General Hospital, Beijing, Beijing Hospital, Beijing Friendship Hospital, Peking University First Hospital, Peking University Third Hospital, China-Japan Friendship Hospital, Beijing Tsinghua Changgeng Hospital
Immune Thrombocytopenia
06/24
06/25
NCT05852847: Low-dose Baricitinib Plus Danazol for Steroid-resistant/Relapse Immune Thrombocytopenia

Recruiting
2
216
RoW
Baricitinib 2 MG [Olumiant], Olumiant, Danazol
Peking University People's Hospital, Beijing Luhe Hospital, Chinese PLA General Hospital, Navy General Hospital, Beijing, Beijing Hospital, Beijing Friendship Hospital, Peking University First Hospital, Peking University Third Hospital, China-Japan Friendship Hospital, Beijing Tsinghua Changgeng Hospital
Immune Thrombocytopenia
11/24
05/25
CRTOG2401, NCT06714708: Low Dose Radiotherapy Combined With Sintilimab and Chemotherapy as Neoadjuvant Therapy for Stage II-III NSCLC

Recruiting
2
86
RoW
Experimental, Active comparator
Anhui Provincial Cancer Hospital
NSCLC, Neoadjuvant Immunotherapy, Low Dose Radiotherapy, Sintilimab
12/26
06/27
JSKN003-102, NCT05744427: Safety and Tolerability of JSKN003 in Chinese Subjects With Advanced Solid Tumors

Hourglass Dec 2024 - Dec 2024 : Results for HER2-low, U/M BC
Recruiting
1/2
725
RoW
JSKN003
Jiangsu Alphamab Biopharmaceuticals Co., Ltd
Advanced Solid Tumor
12/24
12/26
NCT06593093: A Bundled Intervention

Not yet recruiting
1/2
190
US
a bundled intervention, control group
University of Alabama at Birmingham, National Institute on Drug Abuse (NIDA)
Opioid Use Disorder, Opioid Overdose
11/30
11/30
OPAL-1, NCT05970497: A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors

Recruiting
1/2
140
US
KB707, Opdualag
Krystal Biotech, Inc.
Cancer, Melanoma Stage III, Melanoma Stage IV, Cutaneous Melanoma
07/26
07/26
NCT04977193: A Study to Evaluate the Safety and Efficacy of ly011 Cell Injection in the Treatment of Advanced Gastric Adenocarcinoma

Recruiting
1
18
RoW
LY011
Shanghai Longyao Biotechnology Inc., Ltd., The Affiliated Hospital of Xuzhou Medical University
Advanced Gastric Adenocarcinoma
05/23
11/24
TQB2858-Ⅰ-06, NCT05068921: A Clinical Trial to Evaluate Tolerability and Pharmacokinetics of TQB2858 Injection in Subjects With Advanced Malignancy

Recruiting
1
40
RoW
TQB2858 injection
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Advanced Cervical Cancer
05/23
07/23
NCT06678581: SAD,MAD and Food Effect Study of SAP-001 Tablets in Chinese Subjects

Completed
1
70
RoW
SAP-001, SAP-001 tablet, Placebo, placebo tablet
Shanton Pharma Co., Ltd.
Gout, Hyperuricemia
12/23
01/24
DEVIF-I, NCT06230822: Safety, Tolerability and Efficacy of VUM02 Injection in Treatment of Idiopathic Pulmonary Fibrosis (IPF)

Recruiting
1
9
RoW
VUM02 Injection, Human Umbilical Cord Tissue-derived Mesenchymal Stem Cells Injection
Wuhan Optics Valley Vcanbiopharma Co., Ltd.
Idiopathic Pulmonary Fibrosis
01/25
12/26
OASIS, NCT06063317: A Study of OnCARlytics (CF33-CD19) in Combination with Blinatumomab in Adults with Advanced or Metastatic Solid Tumors

Recruiting
1
33
US
CF33-CD19 IT, CF33-CD19 IV, Blinatumomab, Blincyto
Imugene Limited
Solid Tumor, Adult
06/27
05/29
NCT06104241: BGT007 Cells for the Treatment of Refractory Digestive System Tumors

Recruiting
1
14
RoW
BGT007 Injection
The Affiliated Hospital of Xuzhou Medical University, Guangzhou Bioresette Biomedical Technology Co., Ltd.
Gastrointestinal Cancer
10/26
10/27
NCT06104215: BGT007H Cells for the Treatment of Refractory Digestive System Tumors

Recruiting
1
14
RoW
BGT007H Injection
The Affiliated Hospital of Xuzhou Medical University, Guangzhou Bioresette Biomedical Technology Co., Ltd.
Digestive Tract Cancer
10/26
10/27
Solitaire, NCT04692402: Feasibility Trial Evaluating Efficacy and Safety of â„¢ Thrombus Retrieval Device in the Management of Refractory Thrombus in Patients With Acute Coronary Syndrome

Recruiting
N/A
51
RoW
Solitaireâ„¢ thrombus retrieval device
Paul Ong
Refractory Thrombus in Patients With Acute Coronary Syndrome
06/22
09/22
NCT05469152: Detachable String Magnetically Controlled Capsule Endoscopy for Follow-up of Patients With Esophageal Diseases

Recruiting
N/A
310
RoW
ds-MCE and EGD
Changhai Hospital, Ruijin Hospital, Shanghai Zhongshan Hospital, XuHui District Central Hospital, Yangpu District Central Hospital Affiliated to Tongji University, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 6th People's Hospital
Esophageal Diseases
09/22
09/22
NCT05273840: Effect of Nutritional Supplements on Clinical Outcomes in Patients With Prediabetes and Obesity

Recruiting
N/A
100
RoW
Ivital Control, Produced by Fresenius Kabi, Chocolate flavor, Product specifications: 460g (46g*10), lifestyle intervention
Ningbo No. 1 Hospital
PreDiabetes, Obesity
10/22
11/22
NCT03748563: Accuracy of Magnetically Maneuvered Capsule Endoscopy for Detection of EGV in Patients With Cirrhosis

Completed
N/A
607
RoW
ds-MCE and EGD
Changhai Hospital, Ruijin Hospital, Shanghai Tongji Hospital, Tongji University School of Medicine, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai East Hospital of Tongji University, Yangpu District Central Hospital Affiliated to Tongji University, Zhujiang Hospital, Qilu Hospital of Shandong University, The Third Xiangya Hospital of Central South University, First Affiliated Hospital Xi'an Jiaotong University, Wuhan Union Hospital, China, The Fifth Affiliated Hospital of Zunyi Medical College, The First Affiliated Hospital of Zhejiang Chinese Medical University, Shanghai Pudong New Area Gongli Hospital
Liver Cirrhosis, Portal Hypertension, Esophageal Varices, Gastric Varix
01/23
03/23
NCT05561855: T2DM Intensity Lifestyle Intervention

Completed
N/A
120
RoW
lifestyle intervention
Ningbo No. 1 Hospital, Peking University
Diabetes Mellitus, Type 2, Overweight or Obesity
06/23
07/23
NCT06493669: Study on the Correlation Between Treg Immune Cells on the Muscle Content and Cognitive Functions of the Elderly

Recruiting
N/A
100
RoW
Cognitive assessment
Fifth Affiliated Hospital, Sun Yat-Sen University
Cognitive Disorder Patients and Cognitive Assessment
12/24
12/24
NCT06371313: Endocrine, Metabolic and Inflammatory Characteristics of Offspring of Mothers With PCOS Hyperandrogenism

Completed
N/A
42
RoW
Guangdong Women and Children Hospital
PCOS
03/24
03/24
NCT05389254: Association Between Time in Range and In-hospital Outcomes in Type 2 Diabetic Patients With Acute Coronary Syndrome

Not yet recruiting
N/A
100
RoW
continuous glucose monitoring system, capillary blood glucose monitoring
Ningbo No. 1 Hospital
Type 2 Diabetes Mellitus, Acute Coronary Syndrome
06/23
12/23
ARM-SI-ALI, NCT04541264: Radiomics Markers to Predict Sepsis Induced Acute Respiratory Distress Syndrome

Recruiting
N/A
300
RoW
radiomic of chest CT
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Early Prediction for Sepsis Induced Acute Lung Injury
08/23
12/23
NCT05455099: A Multicenter Study of Ultrafast Pulse Wave Velocity in Obese Chinese Han Adults

Recruiting
N/A
2400
RoW
Carotid ultrasound examination 1, Carotid ultrasound examination 2
First Hospital of China Medical University
Carotid Artery Diseases
08/23
07/24
NCT05516641: Prebiotics in Rectal Cancer

Recruiting
N/A
20
US
Soluble Corn Fiber, Maltodextrin
Ochsner Health System
Rectal Cancer
12/23
07/24
NCT05482191: Healthy Weight Management Project for Overweight and Obesity Children

Active, not recruiting
N/A
300
RoW
Lifestyle intervention
Ningbo No. 1 Hospital, Peking University
Obesity
12/23
12/25
NCT05482165: Optimizing Intervention Effects in Children and Adolescents

Active, not recruiting
N/A
1800
RoW
Multi-faceted health promotion programme
Ningbo No. 1 Hospital, Peking University
Childhood Obesity
12/23
12/25
NCT05872425: Efficacy and Safety of Dingkundan Combined With Combination Oral Contraceptives in the Treatment of PCOS

Completed
N/A
120
RoW
DingKunDan(GuangYuYuan), DingKunDan(GuangYuYuan): Z20059003, Drospirenone and Ethinylestradiol Tablets (Ⅱ): H20140972, Drospirenone and Ethinylestradiol Tablets (Ⅱ)
Guangdong Women and Children Hospital
PCOS
04/24
04/24
NCT06256848: Effect of Myofascial Release on Dysphagia in Stroke Survivors

Recruiting
N/A
80
RoW
Rehabilitation treatment, Myofascial Release Therapy
Zeng Changhao, People's Hospital of Zhengzhou University
Dysphagia
05/24
05/24
NCT06249516: Effect of Active Breathing Exercises in Stroke Patients With Respiratory Rhythm Disorder

Not yet recruiting
N/A
80
RoW
Rehabilitation training, Active Breathing Exercises
Zeng Changhao, People's Hospital of Zhengzhou University
Respiratory Rhythm Disorder
06/24
06/24
NCT06427018: Expressions of Ezrin and Pip5k1α Proteins in Airway Smooth Muscle of Asthmatic Patients

Recruiting
N/A
60
RoW
No intervention.
Lei-Miao Yin, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai 6th People's Hospital, Xiangya Hospital of Central South University, Baoshan Hospital, Shanghai University of Traditional Chinese Medicine
Asthma, Protein
06/25
12/25
Al-MDS, NCT05974163: Development of an AI-based Emergency Imaging Multi-Disease Rapid Joint Screening System

Not yet recruiting
N/A
10000
RoW
radiomic of CT
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Emergency Medical Services, Critical Illness, Emergency Service, Hospital, Machine Learning, Diagnosis
07/24
07/25
NCT06606509: The Survey of Treatment and Metabolic Status of Type 1 Diabetes Mellitus (T1DM).

Not yet recruiting
N/A
1000
RoW
Continuous Glucose Monitoring System (GX-01S)
Nanjing First Hospital, Nanjing Medical University
Type1 Diabetes Mellitus
10/26
06/27
SSB and CRC, NCT06669923: Understanding Sugar-Sweetened Beverages (SSB) and Colorectal Cancer (CRC)

Not yet recruiting
N/A
120
NA
iSIPsmarter Program, Sugary Drink Program, Patient Education, Cancer Prevention Program
University of Virginia
Colorectal Neoplasms
11/29
11/30
NCT06737848: The Comparison of Single Catheter and Double Catheter Adrenal Vein Sampling Methods Based on the Upper Limb Approach

Not yet recruiting
N/A
70
NA
Single catheter adrenal vein sampling, Double catheters adrenal vein sampling
Army Medical University, China
Primary Aldosteronism
04/25
07/25
NCT05976529: A Multicenter, Observational Clinical Study of Dydrogesterone

Recruiting
N/A
400
RoW
Guangdong Women and Children Hospital
Endometriosis, Endometriosis Ovary
04/25
12/25
NCT05315492: Strengthening Community Addiction Services in Vietnam

Recruiting
N/A
1620
RoW
Community Care Consortium (CCC)
University of California, Los Angeles
Addiction, Opioid
01/26
07/26
Liu, Wen
NCT06338995: A Study of Lebrikizumab (LY3650150) in Adult Participants With Chronic Rhinosinusitis and Nasal Polyps Treated With Intranasal Corticosteroids (CONTRAST-NP)

Recruiting
3
510
Europe, Canada, Japan, US, RoW
LY3650150, Placebo, Standard therapy for INCS
Eli Lilly and Company
Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)
11/25
10/26
ANCHOR-2, NCT05281523 / 2021-005055-36: Efficacy and Safety of Depemokimab (GSK3511294) in Participants With Chronic Rhinosinusitis With Nasal Polyps

Hourglass Jul 2024 - Dec 2024 : Acceptance of regulatory submission in US (based on ANCHOR-2 trial) for chronic rhinosinusitis with nasal polyps
Completed
3
264
Europe, Japan, US, RoW
Depemokimab (GSK3511294), Placebo
GlaxoSmithKline
Nasal Polyps
07/24
08/24
ACHIEVE, NCT03020303 / 2020-001882-36: Aldosterone BloCkade for Health Improvement EValuation in End-stage Renal Disease

Recruiting
3
2750
Europe, Canada, RoW
Spironolactone 25Mg Tablet, Placebo Oral Tablet
Population Health Research Institute, Canadian Institutes of Health Research (CIHR)
Endstage Renal Disease
07/25
04/26
NCT06322394: BXOS110 Injection in the Treatment of Acute Ischaemic Stroke

Recruiting
2
300
RoW
high-dose BXOS110, BXOS110, low-dose BXOS110, Placebo
Biocells (Beijing) Biotech Co.,Ltd
Acute Ischemic Stroke
03/25
09/25
NCT05865496: A Study to Evaluate 611 in Patients With Chronic Rhinosinusitis With Nasal Polyps

Active, not recruiting
2
90
RoW
611, Placebo
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
Sinusitis, Nasal Polyps, Polyps
05/24
07/24
NCT06451640: A Extension Clinical Study of TQC2731 Injection in the Treatment of Chronic Sinusitis With Nasal Polyps

Recruiting
2
60
RoW
210mg of TQC2731 injection, 420mg of TQC2731 injection
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
Chronic Rhinosinusitis With Nasal Polyps
05/25
02/26
NCT06439381: Long-term Safety and Efficacy of TQH2722 Injection in the Treatment of Chronic Sinusitis With or Without Nasal Polyps

Recruiting
2
120
RoW
300mg/600mg of TQH2722 injection
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Chronic Rhinosinusitis
10/25
11/25
NCT06089278: A Clinical Study of TQH2722 Injection in the Treatment of Chronic Sinusitis With or Without Nasal Polyps.

Recruiting
2
160
RoW
300mg of TQH2722 injection, 600mg of TQH2722 injection, TQH2722 injection matching placebo
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
Sinusitis
05/25
05/25
NCT06036927: A Clinical Study of TQC2731 Injection in the Treatment of Chronic Rhinosinusitis With Nasal Polyps

Recruiting
2
80
RoW
TQC2731 injection, TQC2731 matching placebo
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Chronic Sinusitis, Nasal Polyps
07/25
09/25
HEPCP, NCT04423653: The Feasibility of Telehealth HEP for CP (HEP: Home Exercise Program), (CP: Cerebral Palsy)

Not yet recruiting
N/A
20
US
Telehealth home exercise program
University of Kansas Medical Center
Cerebral Palsy, Spastic, Telemedicine
07/21
07/22
NCT03463330: Benefits of Mild Body Exercises in Parkinson's Disease

Active, not recruiting
N/A
65
US
Qigong exercise, Mild body exercise
University of Kansas Medical Center
Parkinson Disease
02/22
03/22
NCT06247553: To Develop a Walking Exercise Program for Non-ambulatory Stroke Survivors

Recruiting
N/A
72
US
Gait Training, Leg Cycling Exercise
University of Kansas Medical Center
Stroke, Walking, Difficulty, Cardiovascular Injury
09/25
09/25
Li, Jie
NCT03701750: Effect of LMWH on Pregnancy Outcome in Women With Multiple Failures of IVF-ET

Recruiting
4
240
RoW
Low Molecular Weight Heparin (enoxaparin sodium)
Shenzhen Zhongshan Urology Hospital, The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School, Renmin Hospital of Wuhan University
Infertility
10/21
10/22
HS-10234-401, NCT06743438: Long-term Safety and Efficacy of Tenofovir Amibufenamide in Patients With CHB

Active, not recruiting
4
640
RoW
Tenofovir Amibufenamide(TMF), HS-10234
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Hepatitis B, Chronic
06/24
09/29
NCT05229809: Clinical Trial of Yiqi Wenyang Jiedu Prescription in the Prevention and Treatment of Postoperative Metastasis and Recurrence of Gastric Cancer

Recruiting
4
212
RoW
Yiqi Wenyang Jiedu prescription, Simulation agent of Yiqi Wenyang Jiedu prescription
Jie Li
Gastric Carcinoma
07/23
07/24
NCT03708549: Comparison of Berberine and Metformin for the Treatment for MS in Schizophrenia Patients

Recruiting
4
100
RoW
Berberine, Metformin
Tianjin Anding Hospital
Schizophrenia, Metabolic Syndrome, Berberine, Metformin
10/23
12/23
NCT05894694: Survival Benefit of Compound Kushen Injection in the Treatment of Advanced Colorectal Cancer

Recruiting
4
320
RoW
first-line scheme+compound kushen injection, palliative care group first-line scheme
Guang'anmen Hospital of China Academy of Chinese Medical Sciences
Advanced Colorectal Carcinoma
12/25
12/25
NCT04875169: Evaluate Efficacy and Safety of Oral SHR0302 in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis

Completed
3
336
Canada, RoW
Core Treatment Active Experimental: SHR0302 Dose#1, Core Treatment Active Experimental: SHR0302 Dose#2, Core Treatment Placebo Comparator: Placebo, Extension Treatment Active Experimental: SHR0302 Dose#1, Extension Treatment Active Experimental: SHR0302 Dose#2
Reistone Biopharma Company Limited
Atopic Dermatitis
08/22
05/23
NCT05525637: Safety and Efficacy Study of YZJ-1139 in Insomnia Disorder

Recruiting
3
1041
RoW
YZJ-1139 20mg, YZJ-1139 40mg, Placebo
Shanghai Haiyan Pharmaceutical Technology Co., Ltd.
Insomnia Disorder
12/24
12/24
NCT06292013: A Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a)

Recruiting
3
12500
Europe, Canada, Japan, US, RoW
Lepodisiran Sodium, LY3819469, Placebo
Eli Lilly and Company
Atherosclerotic Cardiovascular Disease (ASCVD), Elevated Lp(a)
03/29
03/29
NCT06300177: D-1553 Tablet Versus Docetaxel Injection for KRAS G12C Mutation-positive Locally Advanced or Metastatic Non-small Cell Lung Cancer After Prior Standard Therapy Failure

Recruiting
3
522
RoW
D-1553 Tablet, Docetaxel injection
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Non Small Cell Lung Cancer
10/26
12/27
TQB2450-ALTN-III-01, NCT06469879: A Clinical Study of TQB2450 Combined With Anlotinib in Limited-Stage Small Cell Lung Cancer Patients

Not yet recruiting
3
358
RoW
TQB2450+Anlotinib, TQB2450 placebo + Anlotinib placebo
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Small Cell Lung Cancer Limited Stage
09/26
09/26
NCT03932136: Decreasing Risk of Psychosis by Sulforaphane (DROPS Trial)

Recruiting
3
300
RoW
Sulforaphane, ZHIYINGUOSU, Placebo
Shanghai Jiao Tong University School of Medicine, Shanghai Xuhui District Mental Health Center, Shanghai Pudong Nanhui Mental Health Center, Suzhou Psychiatric Hospital, Second Xiangya Hospital of Central South University, Guangzhou Psychiatric Hospital, Shenzhen Fushan Biotech Co., Ltd., Tianjin Anding Hospital, The First Affiliated Hospital of Zhengzhou University, Shenzhen Kangning Hospital
Clinical High Risk Syndrome of Psychosis
12/25
12/26
NCT06095583: Phase 3 Study of Toripalimab Alone or in Combination With Tifcemalimab as Consolidation Therapy in Patients With Limited-stage Small Cell Lung Cancer (LS-SCLC)

Recruiting
3
756
Europe, US, RoW
Tifcemalimab injection, toripalimab injection, Placebo for Tifcemalimab, Placebo for toripalimab
Shanghai Junshi Bioscience Co., Ltd.
Limited-stage Small Cell Lung Cancer (LS-SCLC)
07/27
07/29
NCT04983043: Efficacy and Safety of QiShen YiQi Dripping Pills in Chronic Heart Failure

Completed
2
228
RoW
Low dose QiShen YiQi Dripping Pills 3 bags, Low dose group, High dose QiShen YiQi Dripping Pills 3 bags, High dose group, QiShen YiQi Dripping Pills placebo 3 bags, Placebo group
Tasly Pharmaceutical Group Co., Ltd
Chronic Heart Failure With Reduced Ejection Fraction
11/24
11/24
GMCAII, NCT06221683: Clinical Study of Induction Therapy Options Based on Molecular Subtyping and MRD in Children and Adolescents With AML

Recruiting
2
500
RoW
Homoharringtonine, Homoharringtonine injection, Cytarabine, Cytosar, Etoposide, Etoposide injection, Venetoclax, Venclexta, Mitoxantrone hydrochloride liposome, Mitoxantrone hydrochloride liposome injection, Recombinant Human Granulocyte Colony-Stimulating Factor, Recombinant Human Granulocyte Colony-Stimulating Factor Injection, Idarubicin Hydrochloride, Idarubicin hydrochloride injection, Sorafenib, Nexavar, Gilteritinib, Xospata Pill, Avapritinib, AYVAKIT
Children's Hospital of Soochow University
AML, Childhood, Acute Myeloid Leukemia
12/28
12/29
NCT06316960: Safety and Efficacy of Avapritinib in Relapsed or Refractory Pediatric CBF-AML With KIT Mutation

Recruiting
2
50
RoW
Avapritinib, AYVAKIT, Azacitidine Injection, Azacitidine, Decitabine Injection, Decitabine, Idarubicin Hydrochloride, Idarubicine, Cytarabine, CYTOSAR, Granulocyte Colony-Stimulating Factor, Recombinant Human Granulocyte Colony-Stimulating Factor Injection
Children's Hospital of Soochow University
AML, Childhood, Relapse/Recurrence, Refractory AML, Core Binding Factor Acute Myeloid Leukemia, C-KIT Mutation
03/26
03/27
NCT06566248: A Clinical Trial to Evaluate the Efficacy and Safety of TQA3810 Tablets in Combination/Non Combination With Nucleoside (Acid) Analogues in Patients With Primary/Treated Chronic Hepatitis B

Recruiting
2
90
RoW
TQA3810 tablets+NUC, Placebo+NUC
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Chronic Hepatitis B
09/24
03/25
NCT06241781: Autologous Tumor Infiltrating Lymphocytes (GT101 Injection) in Patients With Recurrent or Metastatic Cervical Cancer

Recruiting
2
64
RoW
GT101 injection, Gemcitabine injection
Grit Biotechnology
Adult
01/27
01/27
TQB2102-II-03, NCT06496490: A Clinical Trial of TQB2102 for Injection in Non-small Cell Lung Cancer With HER2 Gene Abnormality

Recruiting
2
270
RoW
TQB2102 for injection, TQB2102 for injection combined with Benmelstobart injection
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
Non-Small Cell Lung Cancer
10/25
02/26
NCT05632861: HuHuangLianzonggan Capsule in Subjects With Nonalcoholic Steatohepatitis: a Phase 2 tRial(HHL-HEPAR)

Recruiting
2
76
RoW
HuHuangLianzonggan capsule, Experimental group, HuHuangLianzonggan capsule placebo, Placebo group
Tasly Pharmaceutical Group Co., Ltd
NASH
12/24
12/24
TQB3909-Ib/II-02, NCT05959694: A Clinical Trial on the Safety and Efficacy of TQB3909 Tablets in Patients With Recurrent or Refractory Chronic Lymphocytic Leukemia (CLL) /Small Lymphocytic Lymphoma (SLL) .

Recruiting
1/2
107
RoW
TQB3909 tablet
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
12/25
06/26
CIBI343A101, NCT05458219: A First-in-human Study of IBI343 in Subjects with Locally Advanced Unresectable or Metastatic Solid Tumors

Recruiting
1
470
US, RoW
IBI343
Innovent Biologics (Suzhou) Co. Ltd., Innovent Biologics, Inc., TigerMed
Locally Advanced Unresectable or Metastatic Solid Tumors
12/25
12/25
NCT06325267: Clinical Characteristics of Primary Liver Cancer

Recruiting
N/A
1000
RoW
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Primary Liver Cancer
08/24
08/24
NCT06325254: Clinical Characteristics of Metabolic Associated Fatty Liver Disease

Recruiting
N/A
3000
RoW
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Metabolic Associated Fatty Liver Disease, Clinical Features
08/24
08/24
NCT06524505: Efficacy, Tolerability, and Cognitive Effects of Deep Transcranial Magnetic Stimulation for Bipolar Depression

Recruiting
N/A
100
RoW
deep Transcranial Magnetic Stimulation (dTMS) -active, deep Transcranial Magnetic Stimulation (dTMS) -sham
Tianjin Anding Hospital
Bipolar Depression
10/24
11/24
SBRTLCES, NCT04274270: SBRT With S1 Combined With Endostar in the Treatment of Lung Cancer

Not yet recruiting
N/A
60
RoW
Endostar, S1
Peking University Third Hospital, Mianyang Central Hospital, Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Beijing Cancer Hospital, Peking University International Hospital, China-Japan Friendship Hospital, The fifth medical center of PLA general hospital, Second Hospital of Shanxi Medical University, Hiser Medical Center of Qingdao, Guangxi Ruikang Hospital, GEM flower hospital of Liaohe oil field, Tang-Du Hospital, Third Affiliated Hospital of Guizhou Medical University, Liuzhou Worker's Hospital, The Affiliated Hospital of Xuzhou Medical University, Dalian municipal central hospital affiliated of dalian medical university
Radiotherapy Side Effect
01/22
01/23
ROX-1, NCT04707729: ROX Index for the Timing of Intubation in Nasal High Flow

Recruiting
N/A
630
Europe, US, RoW
ROX index algorithm
Hospital Universitari Vall d'Hebron Research Institute
Acute Hypoxemic Respiratory Failure
12/24
06/25
NCT04564573: Antidepressant Treatments and Cognitive Function of Bipolar Patients

Recruiting
N/A
124
RoW
Tianjin Anding Hospital
Bipolar Disorder, Cognition
07/22
10/22
NCT04562324: Efficacy of Electroencephalography (EEG) Neurofeedback (NF) for the Treatment of Anxiety Disorder

Recruiting
N/A
60
RoW
SSRI or SNRI or benzodiazepines or tricyclic antidepressants or other antidepressants or antipsychotics or other sedative-hypnotics, Neurofeedback system
Tianjin Anding Hospital
Anxiety Disorder, Healthy
10/22
11/23
NCT04497493: Efficacy of Transcranial Direct Current Stimulation (tDCS) for the Treatment of Major Depressive Disorder

Recruiting
N/A
75
RoW
Transcranial Direct Current Stimulation (tDCS)-active, active, Transcranial Direct Current Stimulation (tDCS)-sham, sham
Tianjin Anding Hospital
Major Depressive Disorders
10/22
03/23
NCT06000137: The Comparison of the Analgesic Effects of Dezocine and Sufentanil in Patient-controlled Analgesia After Laryngectomy

Completed
N/A
129
RoW
Dezocine, Sufentanil injection, sufentanil, Flurbiprofen, Granisetron Injection, granisetron
Eye & ENT Hospital of Fudan University
Patient-controlled Analgesia
01/23
01/23
NCT02972398: N-Acetyl Cysteine Supplementation in Therapy Refractory Major Depressive Disorders

Recruiting
N/A
200
RoW
N-acetylcysteine, YiWeiShi, placebo comparator of N-acetylcysteine
Tianjin Anding Hospital
Major Depressive Disorders
07/23
09/23
NCT04971148: Correlation of Peak Tidal Inspiratory Flow Measured Before and After Extubation in Adult Patients With Hypoxemia

Terminated
N/A
5
Europe, US
HFNC flow set at patient peak tidal inspiratory flow, HFNC flow set at 1.33 times of patient peak tidal inspiratory flow, HFNC flow set at 1.67 times of patient peak tidal inspiratory flow, HFNC flow set at 2 times of patient peak tidal inspiratory flow
Rush University Medical Center, Hospital Vall d'Hebron
Hypoxemic Respiratory Failure
08/23
08/23
NCT04341467: Amisulpride Treatment for BPSD in AD Patients

Recruiting
N/A
76
RoW
Amisulpride, Solian, Olanzapine, Oulanning
Tianjin Anding Hospital
BPSD, Amisulpride, Olanzapine, Dementia of the Alzheimer Type
12/23
05/24
INHALE, NCT06135324: Impairments That Affect Correct Inhaler Use in COPD

Recruiting
N/A
500
US
COPD Foundation, Viatris Inc.
COPD
12/24
07/25
PROTECT-2, NCT06134908: PRevention of OsTEoporotiC FracTure 2 Pilot Study

Recruiting
N/A
50
RoW
Multifaceted Intervention
Third Affiliated Hospital, Sun Yat-Sen University, Sir Run Run Shaw Hospital, The Second Affiliated Hospital of Hunan University of Chinese Medicine, Longgang Orthopedics Hospital of Shenzhen, The First People's Hospital of Hefei, Dongguan Eighth People's Hospital, The Third People's Hospital of Longgang District Shenzhen
Fragility Fracture
06/25
06/27
NCT06269419: Study of Natural Course Progression of Diabetic Retinopathy

Recruiting
N/A
200
RoW
Jie Li
Biomarkers of Diabetic Retinopathy
01/29
01/29
NCT06300918: A Clinical Trial to Evaluate the Time Point of Anti-VEGF Pretreatment of PDR Based on Intraoperative FFA

Recruiting
N/A
60
RoW
Time
Jie Li
The Condition of Fundus Neovascularization
08/25
08/25
NCT05932095: TCM Daoyin in the Treatment of Patients With Anxiety State

Recruiting
N/A
20
RoW
TCM Daoyin, Qigong, Health education
Shanghai University of Traditional Chinese Medicine, Shanghai Mental Health Center
Anxiety State
03/24
08/24
 

Download Options